Company Overview

Earth Science Tech, Inc. (ETST) is a U.S.-based life sciences and consumer products company primarily focused on the development, manufacturing, and distribution of hemp-derived and cannabinoid-based products. The company operates at the intersection of the consumer health, nutraceutical, and cannabinoid wellness industries, with an emphasis on legally compliant, non-psychoactive formulations. Its core revenue drivers historically have included branded cannabidiol (CBD) products sold through wholesale, e-commerce, and private-label channels.

The company is positioned as an early entrant in hemp-derived wellness products, leveraging vertically integrated capabilities that span formulation, branding, and distribution. Earth Science Tech was founded in 2010 and initially focused on plant-based and agricultural technologies before pivoting into the hemp-derived CBD market following changes in U.S. regulatory frameworks in the mid-to-late 2010s. Over time, the company expanded into consumer packaged goods and pharmaceutical-adjacent research initiatives, though the commercial scale and consistency of these efforts have varied. Certain aspects of the company’s historical revenue mix and long-term profitability remain limited or inconsistent based on available public disclosures.

Business Operations

Earth Science Tech conducts operations primarily through its subsidiaries and branded business units, including Earth Science Tech Labs, Earth Science Pharmaceutical, and the KannaBidioid consumer brand. The company generates revenue mainly from the sale of hemp-derived CBD products, including tinctures, topicals, cosmetics, and wellness supplements. These products have been marketed through direct-to-consumer platforms, wholesale distributors, and private-label arrangements, primarily within the United States.

Operationally, the company has emphasized in-house product formulation and branding while relying on third-party manufacturers for certain production and logistics functions. Earth Science Tech has also disclosed involvement in cannabinoid-related research and intellectual property development through Earth Science Pharmaceutical, though the extent to which these activities generate material revenue is unclear. The company’s filings indicate limited but ongoing international sales activity; however, detailed segment-level financial breakdowns are not consistently disclosed. Data inconclusive based on available public sources regarding the current scale of each operating unit.

Strategic Position & Investments

Strategically, Earth Science Tech has pursued growth through brand development, selective acquisitions, and expansion into higher-margin cannabinoid-based products. A notable transaction includes the acquisition of Cannabis Science, Inc., which was intended to expand the company’s intellectual property portfolio and pharmaceutical research capabilities related to cannabinoids. Public disclosures indicate that this acquisition was structured to strengthen long-term positioning rather than provide immediate revenue impact.

The company has stated an interest in emerging cannabinoid formulations, delivery mechanisms, and potential pharmaceutical applications, though many of these initiatives remain in early or developmental stages. Investment activity has largely been constrained by capital availability, and the company has relied on equity issuances and debt instruments to fund operations. The commercial viability and execution timeline of several strategic initiatives remain uncertain based on available public filings.

Geographic Footprint

Earth Science Tech is headquartered in Florida, United States, and its primary commercial activities are concentrated in the United States market. The company has reported sales and distribution relationships extending into parts of Europe and Latin America, reflecting an intent to participate in international cannabinoid wellness markets where regulations permit hemp-derived products.

Despite these international ambitions, the majority of disclosed revenue has historically been generated domestically. The company does not report owning significant foreign manufacturing facilities, instead relying on partnerships and distributors for international reach. Data inconclusive based on available public sources regarding the current scale and sustainability of non-U.S. operations.

Leadership & Governance

Earth Science Tech is led by a management team with experience in consumer products, capital markets, and cannabinoid-related businesses. The leadership has articulated a strategy centered on brand expansion, regulatory compliance, and selective investment in cannabinoid science, while navigating the constraints typical of smaller publicly traded companies.

Key executives include:

• Nickolas Tabraue – Chief Executive Officer
• Nickolas Tabraue – Chairman of the Board
• Peter Davidson – Chief Financial Officer (Data inconclusive based on available public sources regarding current tenure and responsibilities)

The company is governed by a board of directors responsible for overseeing strategy, capital allocation, and compliance. Public disclosures provide limited detail on independent board composition and formal governance committees compared to larger exchange-listed peers.